NDC 45629-089

FOTIVDA

Tivozanib

FOTIVDA is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Aveo Pharmaceuticals, Inc.. The primary component is Tivozanib Hydrochloride.

Product ID45629-089_22d362c3-0746-49c4-8109-6f30bfc86cb8
NDC45629-089
Product TypeHuman Prescription Drug
Proprietary NameFOTIVDA
Generic NameTivozanib
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2021-03-10
Marketing CategoryNDA /
Application NumberNDA212904
Labeler NameAVEO Pharmaceuticals, Inc.
Substance NameTIVOZANIB HYDROCHLORIDE
Active Ingredient Strength1 mg/1
Pharm ClassesKinase Inhibitor [EPC], Tyrosine Kinase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 45629-089-01

24 BOTTLE, PLASTIC in 1 CARTON (45629-089-01) > 21 CAPSULE in 1 BOTTLE, PLASTIC
Marketing Start Date2021-03-10
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "FOTIVDA" or generic name "Tivozanib"

NDCBrand NameGeneric Name
45629-089FOTIVDATivozanib
45629-134FOTIVDATivozanib

Trademark Results [FOTIVDA]

Mark Image

Registration | Serial
Company
Trademark
Application Date
FOTIVDA
FOTIVDA
86580973 4984746 Live/Registered
AVEO Pharmaceuticals, Inc.
2015-03-30
FOTIVDA
FOTIVDA
85430468 not registered Dead/Abandoned
AVEO Pharmaceuticals, Inc.
2011-09-23

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.